ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW 2,290.00
-150.00 (-6.15%)
At close: Apr 2, 2026
ABION Market Cap
ABION has a market cap or net worth of 206.33 billion as of April 2, 2026. Its market cap has increased by 20.08% in one year.
Market Cap
206.33B
Enterprise Value
178.00B
Revenue
880.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,290.00
Market Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 206.33B, an increase of 275.95%. That is a compound annual growth rate of 15.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 219.85B | -22.04% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 355.45B |
| TiumBio | 346.32B |
| curacle co.,ltd. | 301.45B |
| NIBEC | 300.63B |
| Kangstem Biotech | 287.81B |
| Bio Solution | 285.48B |
| Genome & Company | 275.31B |
| Ensol Biosciences | 188.71B |